[New antiepileptics in development].
Dannhardt
Gerd
G
Institut für Pharmazie der Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, 55099 Mainz. Dannhardt@uni-mainz.de
Kiefer
Werner
W
D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D002220:Carbamazepine / Q000031:analogs & derivatives / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy*; D000078328:Felbamate; D006801:Humans; D000077287:Levetiracetam; D048448:Phenylcarbamates / Q000627:therapeutic use; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D011409:Propylene Glycols / Q000627:therapeutic use; D014635:Valproic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000927:Anticonvulsants; D048448:Phenylcarbamates; D011409:Propylene Glycols; D001569:Benzodiazepines; D002220:Carbamazepine; D000077287:Levetiracetam; D014635:Valproic Acid; D000078328:Felbamate; D010889:Piracetam